Acura Pharmaceuticals ROA 2012-2021 | ACUR
Current and historical return on assets (ROA) values for Acura Pharmaceuticals (ACUR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Acura Pharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2021-12-31 | $0.00B | $0.00B | 0.00% |
| 2021-09-30 | $0.00B | $0.00B | 0.00% |
| 2021-06-30 | $0.00B | $0.00B | -50.00% |
| 2021-03-31 | $0.00B | $0.00B | -44.44% |
| 2020-12-31 | $0.00B | $0.00B | -88.89% |
| 2020-09-30 | $0.00B | $0.00B | -80.00% |
| 2020-06-30 | $0.00B | $0.00B | -40.00% |
| 2020-03-31 | $0.00B | $0.00B | -177.78% |
| 2019-12-31 | $0.00B | $0.00B | -177.78% |
| 2019-09-30 | $0.00B | $0.00B | -200.00% |
| 2019-06-30 | $-0.01B | $0.00B | -250.00% |
| 2019-03-31 | $0.00B | $0.00B | -133.33% |
| 2018-12-31 | $0.00B | $0.00B | -120.00% |
| 2018-09-30 | $-0.01B | $0.00B | -153.85% |
| 2018-06-30 | $-0.01B | $0.01B | -133.33% |
| 2018-03-31 | $-0.01B | $0.01B | -133.33% |
| 2017-12-31 | $-0.01B | $0.01B | -88.89% |
| 2017-09-30 | $0.00B | $0.01B | -26.67% |
| 2017-06-30 | $0.00B | $0.01B | -25.81% |
| 2017-03-31 | $0.00B | $0.01B | -34.29% |
| 2016-12-31 | $-0.01B | $0.01B | -60.00% |
| 2016-09-30 | $-0.01B | $0.01B | -73.47% |
| 2016-06-30 | $-0.01B | $0.02B | -66.67% |
| 2016-03-31 | $-0.01B | $0.02B | -61.54% |
| 2015-12-31 | $-0.01B | $0.02B | -34.78% |
| 2015-09-30 | $-0.01B | $0.02B | -47.06% |
| 2015-06-30 | $-0.01B | $0.02B | -47.06% |
| 2015-03-31 | $-0.01B | $0.02B | -48.00% |
| 2014-12-31 | $-0.01B | $0.02B | -68.29% |
| 2014-09-30 | $-0.01B | $0.02B | -58.95% |
| 2014-06-30 | $-0.01B | $0.03B | -57.14% |
| 2014-03-31 | $-0.01B | $0.03B | -53.06% |
| 2013-12-31 | $-0.01B | $0.03B | -53.06% |
| 2013-09-30 | $-0.01B | $0.03B | -53.06% |
| 2013-06-30 | $-0.01B | $0.03B | -44.86% |
| 2013-03-31 | $-0.01B | $0.03B | -37.29% |
| 2012-12-31 | $-0.01B | $0.03B | -28.13% |
| 2012-09-30 | $-0.01B | $0.03B | -23.53% |
| 2012-06-30 | $-0.01B | $0.04B | -22.22% |
| 2012-03-31 | $0.01B | $0.04B | 28.95% |
| 2011-12-31 | $0.01B | $0.04B | 28.57% |
| 2011-09-30 | $0.01B | $0.03B | 28.13% |
| 2011-06-30 | $0.01B | $0.03B | 27.59% |
| 2011-03-31 | $-0.01B | $0.03B | -46.15% |
| 2010-12-31 | $-0.01B | $0.03B | -46.85% |
| 2010-09-30 | $-0.01B | $0.03B | -47.46% |
| 2010-06-30 | $-0.02B | $0.03B | -47.62% |
| 2010-03-31 | $-0.02B | $0.03B | -56.72% |
| 2009-12-31 | $-0.02B | $0.04B | -43.84% |
| 2009-09-30 | $-0.02B | $0.04B | -38.22% |
| 2009-06-30 | $-0.01B | $0.04B | -18.93% |
| 2009-03-31 | $0.01B | $0.04B | 13.79% |
| 2008-12-31 | $0.01B | $0.04B | 32.75% |
| 2008-09-30 | $0.03B | $0.04B | 62.07% |
| 2008-06-30 | $0.02B | $0.04B | 61.97% |
| 2008-03-31 | $0.01B | $0.03B | 51.49% |
| 2007-12-31 | $0.00B | $0.02B | -18.75% |
| 2007-09-30 | $-0.03B | $0.01B | -580.00% |
| 2007-06-30 | $-0.03B | $0.00B | -1714.29% |
| 2007-03-31 | $-0.03B | $0.00B | -1550.00% |
| 2006-12-31 | $-0.03B | $0.00B | -1300.00% |
| 2006-09-30 | $-0.02B | $0.00B | -850.00% |
| 2006-06-30 | $-0.02B | $0.00B | -800.00% |
| 2006-03-31 | $-0.01B | $0.00B | -622.22% |
| 2005-12-31 | $-0.01B | $0.00B | -436.36% |
| 2005-09-30 | $-0.01B | $0.00B | -200.00% |
| 2005-06-30 | $-0.06B | $0.01B | -1244.44% |
| 2005-03-31 | $-0.07B | $0.01B | -1107.69% |
| 2004-12-31 | $-0.07B | $0.01B | -811.76% |
| 2004-09-30 | $-0.08B | $0.01B | -911.11% |
| 2004-06-30 | $-0.04B | $0.01B | -409.52% |
| 2004-03-31 | $-0.04B | $0.01B | -344.19% |
| 2003-12-31 | $-0.05B | $0.01B | -435.56% |
| 2003-09-30 | $-0.07B | $0.01B | -512.28% |
| 2003-06-30 | $-0.07B | $0.01B | -501.82% |
| 2003-03-31 | $-0.07B | $0.01B | -490.57% |
| 2002-12-31 | $-0.06B | $0.01B | -472.00% |
| 2002-09-30 | $-0.03B | $0.01B | -247.62% |
| 2002-06-30 | $-0.02B | $0.01B | -181.82% |
| 2002-03-31 | $-0.02B | $0.01B | -160.00% |
| 2001-12-31 | $-0.01B | $0.01B | -101.96% |
| 2001-09-30 | $-0.01B | $0.01B | -80.00% |
| 2001-06-30 | $-0.01B | $0.02B | -83.87% |
| 2001-03-31 | $-0.01B | $0.02B | -41.18% |
| 2000-12-31 | $-0.01B | $0.02B | -64.71% |
| 2000-09-30 | $-0.02B | $0.02B | -92.31% |
| 2000-06-30 | $-0.02B | $0.02B | -106.67% |
| 2000-03-31 | $-0.02B | $0.02B | -140.00% |
| 1999-12-31 | $-0.02B | $0.01B | -140.35% |
| 1999-09-30 | $-0.02B | $0.02B | -104.92% |
| 1999-06-30 | $-0.02B | $0.02B | -96.77% |
| 1999-03-31 | $-0.01B | $0.02B | -88.89% |
| 1998-12-31 | $-0.01B | $0.02B | -75.36% |
| 1998-09-30 | $-0.02B | $0.02B | -98.36% |
| 1998-06-30 | $-0.01B | $0.01B | -100.00% |
| 1998-03-31 | $-0.01B | $0.01B | -112.00% |
| 1997-12-31 | $-0.02B | $0.01B | -146.34% |
| 1997-09-30 | $-0.02B | $0.01B | -133.33% |
| 1997-06-30 | $-0.02B | $0.01B | -125.49% |
| 1997-03-31 | $-0.02B | $0.01B | -112.28% |
| 1996-12-31 | $-0.02B | $0.02B | -90.91% |
| 1996-09-30 | $-0.01B | $0.02B | -71.23% |
| 1996-06-30 | $-0.01B | $0.02B | -56.41% |
| 1996-03-31 | $-0.01B | $0.02B | -45.00% |
| 1995-12-31 | $0.00B | $0.02B | -14.81% |
| 1995-09-30 | $0.00B | $0.02B | -9.88% |
| 1995-06-30 | $0.00B | $0.02B | -4.94% |
| 1995-03-31 | $0.00B | $0.02B | -4.82% |
| 1994-12-31 | $-0.01B | $0.02B | -23.53% |
| 1994-09-30 | $-0.01B | $0.02B | -30.77% |
| 1994-06-30 | $-0.01B | $0.03B | -36.73% |
| 1994-03-31 | $-0.01B | $0.03B | -41.51% |
| 1993-12-31 | $-0.01B | $0.03B | -37.61% |
| 1993-09-30 | $-0.01B | $0.03B | -22.40% |
| 1993-06-30 | $0.00B | $0.03B | -9.45% |
| 1993-03-31 | $0.00B | $0.03B | 3.17% |
| 1992-12-31 | $0.00B | $0.03B | 6.72% |
| 1992-09-30 | $0.00B | $0.03B | 10.62% |
| 1992-06-30 | $0.00B | $0.03B | 7.62% |
| 1992-03-31 | $0.00B | $0.02B | 4.12% |
| 1991-12-31 | $0.00B | $0.02B | 0.00% |
| 1991-09-30 | $0.00B | $0.02B | 0.00% |
| 1991-06-30 | $0.00B | $0.02B | 0.00% |
| 1991-03-31 | $0.00B | $0.02B | 0.00% |
| 1990-12-31 | $0.00B | $0.02B | 0.00% |
| 1990-09-30 | $0.00B | $0.02B | -5.88% |
| 1990-06-30 | $0.00B | $0.02B | -6.06% |
| 1990-03-31 | $0.00B | $0.02B | -6.25% |
| 1989-12-31 | $0.00B | $0.02B | -6.45% |
| 1989-09-30 | $0.00B | $0.01B | 7.02% |
| 1989-06-30 | $0.00B | $0.01B | 8.00% |
| 1989-03-31 | $0.00B | $0.01B | 9.30% |
| 1988-12-31 | $0.00B | $0.01B | 11.11% |
| 1988-09-30 | $0.00B | $0.01B | 0.00% |
| 1988-06-30 | $0.00B | $0.01B | 0.00% |
| 1988-03-31 | $0.00B | $0.01B | 0.00% |
| 1987-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |